Morgan Stanley lowered the firm’s price target on CSX (CSX) to $28 from $29 and keeps an Equal Weight rating on the shares. Q4 was “a modest miss,” but the focus will be on the 2025 guidance given the $350M of net headwinds mgmt. is expecting next year, the analyst tells investors. Some of the actions that will likely drive a year-over-year EBIT decline will pay long-term dividends, but consensus needs to come down through 2027 first, the analyst argues.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CSX:
